NO822592L - PROCEDURE FOR THE PREPARATION OF CAPSULAR BACTERY POLYOSIDES - Google Patents
PROCEDURE FOR THE PREPARATION OF CAPSULAR BACTERY POLYOSIDESInfo
- Publication number
- NO822592L NO822592L NO822592A NO822592A NO822592L NO 822592 L NO822592 L NO 822592L NO 822592 A NO822592 A NO 822592A NO 822592 A NO822592 A NO 822592A NO 822592 L NO822592 L NO 822592L
- Authority
- NO
- Norway
- Prior art keywords
- capsular
- polyosides
- bacteriae
- give
- retained material
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0266—Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) Process for the production of immunogenic capsular polyosides from capsulated bacteriae containing same, characterised in that it consists in cultivating the bacteriae in a synthetic medium which may contain up to about 0.5% by weight of naturally occuring materials ; at the end of the growth stage of said culture removing the microbial bodies, submitting the liquid phase after removal of the microbial bodies to a filtration through a membrane which retains the molecules of a molecular weight of 100 000 daltons or more, to give a capsular polyosides-rich retained material ; and removing the proteins, the nucleic acids and the lipids from said retained material, to give a purified capsular polyoside. 1. Claims (for the Contracting State AT) Process for the production of immunogenic capsular polyosides from capsulated bacteriae containing same, characterised in that it consists in cultivating the bacteriae in a synthetic medium which may contain up to about 0.5% by weight of naturally occuring materials ; at the end of the growth stage of said culture removing the microbial bodies, submitting the liquid phase after removal of the microbial bodies to a filtration through a membrane which retains the molecules of a molecular weight of 100 000 daltons or more, to give a capsular polyosides-rich retained material ; and removing the proteins, the nucleic acids and the lipids from said retained material, to give a purified capsular polyoside.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8114842A FR2510606A1 (en) | 1981-07-30 | 1981-07-30 | PROCESS FOR OBTAINING CAPSULAR POLYOSIDES, CAPSULAR POLYOSIDES THUS OBTAINED AND THEIR APPLICATION TO THE PREPARATION OF VACCINES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO822592L true NO822592L (en) | 1983-01-31 |
| NO159394B NO159394B (en) | 1988-09-12 |
| NO159394C NO159394C (en) | 1988-12-21 |
Family
ID=9261011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO822592A NO159394C (en) | 1981-07-30 | 1982-07-28 | PROCEDURE FOR THE PREPARATION OF IMMUNOGENIC CAPSULATED POLYOSIDES FROM Capsule Bacteria. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0071515B1 (en) |
| AT (1) | ATE16244T1 (en) |
| CA (1) | CA1206905A (en) |
| DD (1) | DD202623A5 (en) |
| DE (1) | DE3267160D1 (en) |
| DK (1) | DK327182A (en) |
| ES (1) | ES514496A0 (en) |
| FR (1) | FR2510606A1 (en) |
| IE (1) | IE53582B1 (en) |
| NO (1) | NO159394C (en) |
| PT (1) | PT75301B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0238739B1 (en) * | 1986-03-27 | 1992-02-05 | Swiss Serum and Vaccine Institute Berne | Klebsiella capsular polysaccharide vaccine |
| US6426074B1 (en) * | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
| DK1268844T3 (en) * | 2000-03-16 | 2009-11-16 | Philadelphia Children Hospital | Modulation of preparation of pneumococcus capsular polysaccharide |
| NZ511680A (en) | 2001-05-14 | 2004-07-30 | Univ Waikato | Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases |
| GB0522303D0 (en) * | 2005-11-01 | 2005-12-07 | Chiron Srl | Culture method |
| EP2155244B1 (en) | 2007-04-23 | 2017-03-22 | Serum Institute of India Private Limited | Antigenic polysaccharides and process for their preparation |
| WO2011148382A1 (en) | 2010-05-28 | 2011-12-01 | Biological E Limited | An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol. |
| WO2011151841A1 (en) * | 2010-05-31 | 2011-12-08 | Panacea Biotec Limited | Fermentation process for streptococcus pneumoniae |
| BR112019013475A2 (en) | 2016-12-30 | 2020-02-27 | Sutrovax, Inc. | POLYPEPTIDE-ANTIGEN CONJUGATES WITH NON-NATURAL AMINO ACIDS |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| WO2020010016A1 (en) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Self-adjuvanted immunogenic conjugates |
| WO2024062494A1 (en) | 2022-09-19 | 2024-03-28 | Biological E Limited | Method for the purification of capsular polysaccharides |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2166963A (en) * | 1936-11-19 | 1939-07-25 | Sharp & Dohme Inc | Antigenic polysaccharide complex |
| US2528972A (en) * | 1947-05-15 | 1950-11-07 | Western Reserve University | Prophylactic toxoid compound and method of making same |
| FR2407262A1 (en) * | 1977-10-27 | 1979-05-25 | Cassenne Lab Sa | NEW POLYSACCHARIDES MICROBIAL BODY EXTRACTS OF HAEMOPHILUS INFLUENZAE, PROCESS FOR THE PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS OF THESE NEW PRODUCTS |
| CA1115210A (en) * | 1977-11-28 | 1981-12-29 | Dennis J. Carlo | Pneumococcal vaccine |
| US4264764A (en) * | 1979-01-12 | 1981-04-28 | Merck & Co., Inc. | Meningitis vaccine |
| US4221906A (en) * | 1979-03-19 | 1980-09-09 | American Cyanamid Company | Stabilization of pneumococcal polysaccharides |
| US4307080A (en) * | 1979-09-24 | 1981-12-22 | Merck & Co., Inc. | Meningitis vaccine |
| US4287173A (en) * | 1979-09-24 | 1981-09-01 | Merck & Co., Inc. | Vaccine for dental caries |
-
1981
- 1981-07-30 FR FR8114842A patent/FR2510606A1/en active Granted
-
1982
- 1982-07-15 IE IE1705/82A patent/IE53582B1/en unknown
- 1982-07-19 EP EP82401343A patent/EP0071515B1/en not_active Expired
- 1982-07-19 AT AT82401343T patent/ATE16244T1/en not_active IP Right Cessation
- 1982-07-19 DE DE8282401343T patent/DE3267160D1/en not_active Expired
- 1982-07-21 DK DK327182A patent/DK327182A/en not_active Application Discontinuation
- 1982-07-23 PT PT75301A patent/PT75301B/en not_active IP Right Cessation
- 1982-07-28 CA CA000408233A patent/CA1206905A/en not_active Expired
- 1982-07-28 NO NO822592A patent/NO159394C/en unknown
- 1982-07-29 DD DD82242065A patent/DD202623A5/en unknown
- 1982-07-29 ES ES514496A patent/ES514496A0/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| EP0071515B1 (en) | 1985-10-30 |
| DD202623A5 (en) | 1983-09-28 |
| IE821705L (en) | 1983-01-30 |
| DK327182A (en) | 1983-01-31 |
| PT75301B (en) | 1984-07-31 |
| PT75301A (en) | 1982-08-01 |
| ATE16244T1 (en) | 1985-11-15 |
| EP0071515A1 (en) | 1983-02-09 |
| NO159394C (en) | 1988-12-21 |
| ES8305827A1 (en) | 1983-04-16 |
| CA1206905A (en) | 1986-07-02 |
| IE53582B1 (en) | 1988-12-21 |
| DE3267160D1 (en) | 1985-12-05 |
| FR2510606B1 (en) | 1984-10-26 |
| FR2510606A1 (en) | 1983-02-04 |
| NO159394B (en) | 1988-09-12 |
| ES514496A0 (en) | 1983-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO822592L (en) | PROCEDURE FOR THE PREPARATION OF CAPSULAR BACTERY POLYOSIDES | |
| ATE469244T1 (en) | METHOD FOR PRODUCING DOCOSAHEXANIC ACID AND DOCOSAPENTOIC ACID | |
| ATE91155T1 (en) | PROCESS FOR PREPARING NUCLEIC ACID FOR HYBRIDIZATION. | |
| HUT45275A (en) | Improved process for transformation of protoplasts of plants | |
| EP0387567A3 (en) | Amphoteric polyelectrolyte, method for production thereof, and organic sludge dehydrater | |
| DE69112463D1 (en) | Device for the production of monocrystals according to the Czochralski process. | |
| DE3681811D1 (en) | METHOD FOR THE CONTINUOUS PRODUCTION OF L-CARNITINE. | |
| NO875319L (en) | PROCEDURE FOR EXTRACELLULAR PREPARATION OF HOMOPOLYSACCARIDES. | |
| DE69109886D1 (en) | Process for the preparation of human factor VIII and its analogs. | |
| FR2545099B1 (en) | NOVEL STRAIN OF TRICHODERMA HARZIANUM METHOD FOR ISOLATING THIS STRAIN, METHOD FOR CULTURING THIS STRAIN, NEW PEPTIDES PRODUCED BY THIS STRAIN, AND APPLICATION OF THIS STRAIN AND THESE NEW PEPTIDES OR THE PRODUCT OBTAINED BY THE CULTURE PROCESS AS A MEANS OF BIOLOGY IN THE FORM OF A PHYTOSANITARY PRODUCT | |
| ATE1552T1 (en) | METHODS OF MAINTAINING LIVING MICROORGANISMS. | |
| ATE9100T1 (en) | TRICHOSPORON KASHIWAYAMA IFO 1964, CULTURE BROTH, CELL-FREE STERILE LIQUID, STERILE FILTRATE, STERILE SUPERNATANT, STERILE CONCENTRATE AND STERILE DRY PRODUCT OF CULTURE BROTH, PROCESS FOR PREPARATION OF CULTURE BROTH, PHARMACEUTICAL COMPOSITION, COSMETIC TO COMPOSITION. | |
| DE68912236D1 (en) | Process for the production of highly unsaturated fatty acids. | |
| JPS5329978A (en) | Cultivation medium | |
| ATE21033T1 (en) | PROCESS FOR THE PRODUCTION OF AN IMMUNOGEN FROM PASTEURELLA MULTOCIDA. | |
| FR2338256A1 (en) | NEW ARYLOXY (THIO) CARBONYLAMINOMETHYL ESTERS OF PHENOXYCARBOXYLIC ACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS PLANT GROWTH SUBSTANCES | |
| JPS5675095A (en) | Preparation of heat-resistant acetic acid kinase | |
| ATE2339T1 (en) | METHOD OF PRODUCTION OF SPHINGOMYELINASE, SPHINGOMYELINASE AND THEIR USE. | |
| JPS5682095A (en) | Purification of fatty acid produced through fermentation process | |
| RU93028311A (en) | METHOD FOR PRODUCING BIOLOGICALLY ACTIVE SUBSTANCES FROM BIOMASS OF CULTIVATED PLANT CELLS | |
| DE69012903D1 (en) | METHOD FOR PRODUCING AND CLEANING HEPATITIS B VACCINE. | |
| JPS55149297A (en) | Antibiotic herbicidin c, e, f, and g and its preparation | |
| RU94025893A (en) | Method of isolation of biologically active substances | |
| JPS55165799A (en) | Preparation of hopan-22-ol and hopene-b | |
| JPS5554898A (en) | Preparation of 3-o-demethyl-fortimicin a |